Karnataka polls: 391 candidates facing criminal cases; 883 crorepatis; BJP No.1 in both

coastaldigest.com web desk
May 7, 2018

Bengaluru, May 7: Out of the 2560 candidates in the Karnataka elections fray, 391 have self-declared criminal cases against them while 254 of them have “serious criminal cases” in their names.  A total of 883 candidates are crorepatis, including 208 from the BJP and 207 from Congress.

The Association for Democratic Reforms (ADR) and Karnataka Election Watch have analysed affidavits of 2560 candidates out of the 2655 and released a report days ahead of the May 12 elections.

The analysis shows that four candidates have declared cases related to murder (Section 302 of the Indian Penal Code). As many as 23 candidates are facing cases related to crimes against women.

The ADR report says, among all major parties contesting the elections, BJP has the most number of candidates with criminal cases, followed by Congress and JD(S).

Out of the 224 BJP candidates, 83 or 37% have criminal cases of varied degrees against them while 59 or 27% of the 220 candidates from Congress have similar cases in their names.

JD(S) has 41 such candidates among its 199 contenders while Nitish Kumar’s JD(U), too, has 5 candidates out of its 25, with criminal records. Five of AAP’s candidates too have such dubious records while 108 out of the 1,090 Independent candidates have declared criminal cases against themselves in their affidavits.

Again, in the “serious criminal cases” category too, BJP has the maximum number of candidates with such offences followed by Congress and JD(S).

Among major parties, 58 BJP candidates have serious criminal records while 32 of 220 Congress candidates and 29 JD(S) candidates similar records.

The ADR has also declared 56 Karnataka seats as “red alert constituencies” where there are at least 3 candidates in the poll fray with declared criminal records.

The percentage of crorepatis in the BJP has jumped from 72% in 2013 to 93%. In the Congress, the number went up from 88% to 94%, though affidavits of two candidates were yet to be analysed. The JD(S) has 77% crorepatis, as against 70% in 2013.

Harish Narasappa, state coordinator of KEW, said heads of the political parties seem to be giving more importance to the candidates’ money power rather than their leadership qualities or parliamentary knowledge. “It seems they think 15 such (knowledgeable leaders) are enough to lead party and pick the rest among those who can supply money,” he said.

Comments

Raghavendra
 - 
Monday, 7 May 2018

Italian bar dancer and her family looted much in India. You people are simply defaming BJP and Modiji

Sangeeth
 - 
Monday, 7 May 2018

Congress looted India from independence. That will not be a issue for presstitutes

Yogesh
 - 
Monday, 7 May 2018

Congi paid news. Vote for BJP

Danish
 - 
Monday, 7 May 2018

When people will start to think properly...?

Mohan
 - 
Monday, 7 May 2018

Another golden feather on BJP's hat. Congrats. shame on you BJP followers

Ganesh
 - 
Monday, 7 May 2018

BJP already proved that. No need of statistics

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 11,2020

Shivamogga, Jan 11: Members of Karnataka Congress women's wing staged a protest in Shivamogga on Friday against the rise in onion prices and domestic LPG (liquefied petroleum gas) cylinders.

As a mark of protest, the demonstrators wore garlands made of onions, drew rangoli on the road and cooked food with firewood. The protestors also carried posters comparing the price of cylinders in Congress and BJP-led government in the Centre.

The price of non-subsidised LPG was hiked by Rs 19 per cylinder from January 1, 2020.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

New Delhi, Mar 4: Tech giant Intel has said one of its employees in Bengaluru has "potentially been exposed" to coronavirus and is currently under quarantine.

The company also said it has implemented precautionary measures like travel restrictions, increased frequency of office sanitisation, and work-from-home provisions in India.

"An Intel employee in Bangalore has potentially been exposed and is currently under quarantine in accordance with government requirements," Intel said in a late night statement on Tuesday.

The company said it is monitoring the coronavirus situation closely and working to ensure that its employees have the information and resources they need to stay safe and informed.

In India, we have implemented precautionary measures such as travel and event restrictions, visitor screenings at all our offices, increased frequency of office sanitisation, and work-from-home provisions," it said.

The virus outbreak, which has seen cases being registered across the world including South Korea, Iran, Italy and Japan, has had a significant impact on businesses across industries.

Microblogging platform Twitter has asked its employees to work from home while other tech giants like Tata Consultancy Services and HCL Technologies instructed staff to avoid non-essential travel as IT firms put in place measures to safeguard workers against the deadly coronavirus.

The coronavirus outbreak claimed over 3,000 lives globally, and fresh cases being reported in India.

The government has stepped up its efforts to detect and check the virus outbreak whose epicentre was in China.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.